Trial Details

RECRUITING
Basic Information
Clinical ID c1149
Identifier NCT06469424
Trial Title An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
City Bonheiden
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2024-01-11
Primary Completion Date 2025-03-31
Completion Date 2026-03-31